SUSTIVA (Bristol-Myers Squibb Pharma Company)
Welcome to the PulseAid listing for the SUSTIVA drug offered from Bristol-Myers Squibb Pharma Company. This Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Non-Nucleoside Analog [Chemical/Ingredient],Non-Nucleoside Reverse Transcriptase Inhibitors [MoA],Cytochrome P450 3A Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA],Cytochrome P450 2C9 Inhibitors [MoA],Cytochrome P450 2C19 Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Bristol-Myers Squibb Pharma Company |
| NON-PROPRIETARY NAME: | Efavirenz |
| SUBSTANCE NAME: | EFAVIRENZ |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Non-Nucleoside Analog [Chemical/Ingredient],Non-Nucleoside Reverse Transcriptase Inhibitors [MoA],Cytochrome P450 3A Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA],Cytochrome P450 2C9 Inhibitors [MoA],Cytochrome P450 2C19 Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE, GELATIN COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1998-09-17 |
| END MARKETING DATE: | 0000-00-00 |
SUSTIVA HUMAN PRESCRIPTION DRUG Details:
| Item Description | SUSTIVA from Bristol-Myers Squibb Pharma Company |
| LABELER NAME: | Bristol-Myers Squibb Pharma Company |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 50(mg/1) |
| START MARKETING DATE: | 1998-09-17 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0056-0470_435037ad-fec4-4cbb-b41a-d8791c1142b4 |
| PRODUCT NDC: | 0056-0470 |
| APPLICATION NUMBER: | NDA020972 |
Other EFAVIRENZ Pharmaceutical Manufacturers / Labelers:
